Based on the results of the core signaling pathways and the discussion of protein/gene expressions [64,65], the significant biomarkers TF LEF1 and TF MYC are chosen as the drug targets for the common oncogenic mechanisms between MIBC and ABC. This evidence concerns the gene MYC and aneurysmal bone cyst.